TK1 and breast cancer: The aim of this work was to correlate the expression of TK1 in tumoral specimens of BC with patients’ prognosis, particularly in terms of distant recurrence-free survival (DRFS), in order to define a cut-off-value to be used in routine practice for the stratification of the risk of relapse and, consequently, tailor the best management individually for each patient.